Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.
J Bone Miner Metab
; 37(3): 554-562, 2019 May.
Article
in En
| MEDLINE
| ID: mdl-30187273
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis
/
Rheumatic Diseases
/
Bone Density Conservation Agents
/
Denosumab
/
Glucocorticoids
Type of study:
Diagnostic_studies
/
Incidence_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Bone Miner Metab
Journal subject:
METABOLISMO
Year:
2019
Document type:
Article
Affiliation country:
Japón
Country of publication:
Japón